Image Credit: Health and me
There's been an alarming increase of respiratory and gastrointestinal viruses in the United States lately, causing anxiety about a so-called "quad-demic". According to surveillance reports, influenza, COVID-19, RSV and norovirus are at very high levels everywhere. While the surge aligns with patterns typical for this season, several epidemiologists view simultaneous infections of such proportions to pose risks not only to individual healthcare but public health.
The incidence of the quad-demic should vary with seasonal patterns, vaccination rates, and public health interventions. Each virus alone is relatively easy to manage; however, the effect of all together could lead to overburdening of health care facilities and increase risks for those at higher risk. Continuing surveillance, early testing, and proactive prevention measures will play an important role in the control of these infections going forward.
While the term "quad-demic" sounds daunting, it must be taken into perspective. For years, we have had all these viruses together, and we have the capabilities to mitigate some of the risk. Vaccination, proper hygiene and using common sense helps individuals get through the season unscathed. Is the quad-demic a permanent fixture or just another seasonal wave? Let's break this down.
Typically, flu, COVID-19, and RSV have been the primary culprits behind seasonal respiratory infections. However, norovirus, a highly contagious stomach bug, has emerged as a fourth significant player, inducing fears of a more severe and widespread viral outbreak. According to the Centers for Disease Control and Prevention (CDC), the U.S. recorded nearly 500 norovirus outbreaks between August and December 2023, a substantial rise from the previous year’s numbers.
While the term "quad-demic" may sound ominous, the seriousness and consequences of such infections should be weighed in light of the U.S. healthcare system's experience with managing viral surges since the start of the COVID-19 pandemic.
Flu continues to be one of the most common and alarming seasonal illnesses. In the period spanning from 2023 to 2024, there were approximately 40 million cases of flu, and thousands of hospitalizations along with reported 47 deaths have been reported this season. Flu symptoms include fever, chills, cough, sore throat, muscle pain, and fatigue, with most recovering within a week or two but risky factors for severe illness effects occur in young children, elderly, and people with chronic conditions.
Despite its reduction from the first pandemic peak, COVID-19 is still rampant. The CDC estimates that alone between October and December 2023, there were between 2.7 and 5 million cases in the U.S. Hospitalization has increased by cities such as Los Angeles, Chicago, and New York. Symptoms are closely similar to the flu, fever, cough, and fatigue but uniquely presents in some cases as loss of taste and smell.
RSV is the most common cause of lower respiratory infections in infants, older adults, and immunocompromised individuals. While RSV peaked late in 2023 and early 2024, it continues to be a threat because it can lead to bronchiolitis and pneumonia. It is very similar to the common cold, presenting with symptoms such as congestion, runny nose, coughing, and fever, which can make it difficult to differentiate from flu or COVID-19 without testing.
Norovirus, also called the "stomach flu," is a highly contagious infection of the gastrointestinal tract, not a respiratory virus. It transmits quickly from contaminated food and water and contact with contaminated surfaces, causing such symptoms as diarrhea, vomiting, nausea, and stomach pain. Cases have shot up, the CDC said Monday, with reports of outbreaks surging compared with last year.
The greatest challenge during the quad-demic is how the four viruses are alike and thus make identification very hard with no testing applied. Most cases present symptoms common to all viruses: fever, tiredness, body pains, and respiratory, which includes coughing and congestions for influenza, COVID-19, and RSV; the other would be norovirus symptoms as nausea and vomiting can appear even in extreme influenza and COVID-19. This overlap increases the risk of misdiagnosis and delayed treatment, hence the need for early testing and proper medical guidance.
Also Read: Is US Preparing For A Quad- demic 2025?
The best defense against these viruses is a combination of vaccines, hygiene, and lifestyle precautions. While lifestyle modifications are highlighted as part of the constant need to eat healthy, ensure daily movement and drinking adequate amount of fluids. There is a sure short two preventive strategies that are effective:
While debates on masked wear continue on, experts on mask-wear affirm that this does not only have a historical precedent but works towards reducing airborne viruses spreading within the environments. Hospitals, though, ensure masking in key sections of themselves. Publicized mask-wear remains a discretion, though massing indoors still goes a longer way in cases like peak flu seasons.
If you notice the symptoms of these viruses, then it's best to be confined at home and avoid having face-to-face interaction with others and seek immediate attention from your physician if your condition worsens. Quarantining for some days can decrease the spread of infection.
As we move into the first half of 2025 and beyond, staying informed and proactive is the best strategy for maintaining health and avoiding unnecessary panic. The key takeaway? Stay vigilant, but don’t be alarmed—these viruses are here, but so are the means to fight them.
Credits: iStock
The World Health Organization (WHO) issued its first-ever recommendation endorsing GLP-1 medications as part of a long term strategy to manage obesity in adults. Earlier, in the guidance to deal with obesity, the main focus was given to diet and lifestyle changes. Thus, this is a big shift from how the UN agency has traditionally approached obesity treatment.
Until now, WHO guidelines only focused on lifestyle changes including physical activity and diet. The new recommendation acknowledges that medication can play a supportive role when combined with counseling on healthy eating and regular exercise.
Published in the Journal of the American Medical Association (JAMA), the guideline describes long-term use as continuous treatment for at least six months. In its note, WHO called obesity a “chronic, relapsing disease” that affects more than one billion people worldwide and contributes substantially to illness, early death, and economic strain on health systems. GLP-1 therapies, the organization wrote, offer “clinically meaningful weight loss and broad metabolic benefits” when used appropriately.
GLP-1 drugs mimic the action of the natural hormone GLP-1 to regulate blood sugar and promote weight loss. They work by increasing insulin release in a glucose-dependent manner, decreasing the liver's production of glucagon, and slowing down the emptying of the stomach, which helps lower blood sugar levels after a meal. They also act on the brain to suppress appetite and increase feelings of fullness, leading to reduced calorie intake.
In people with type 2 diabetes, notes Harvard Health, the body's cells are resistant to the effects of insulin and body does not produce enough insulin, or both. This is when GLP-1 agonists stimulate pancreas to release insulin and suppress the release of another hormone called glucagon.
These drugs also act in the brain to reduce hunger and act on the stomach to delay emptying, so you feel full for a longer time. These effects can lead to weight loss, which can be an important part of managing diabetes.
In September, WHO added GLP-1 drugs to its list of essential medicines, but only for treating diabetes, not for obesity alone. The new guideline extends that conversation, offering a more formal stance on their use in obesity management. The recommendations were developed by a committee of experts in obesity, pharmacology, and public health, following requests from several WHO member states. They also align with approvals already granted by regulators like the U.S. Food and Drug Administration.
Obesity is now recognized as one of the most widespread health concerns worldwide, linked to an increased risk of chronic conditions, including cancers, heart disease, and metabolic disorders. Beyond physical health, it also impacts mental well-being and quality of life. With more than a billion people affected globally, the economic burden on healthcare systems continues to grow.
Also Read: Only 1 in 10 People With Obesity Have Access To Popular GLP-1 Weight-Loss Drugs, Says WHO
However, the accessibility still remains a major issue. n the United States, the most widely used medications: Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy, carry list prices exceeding $1,000 per month. Recently, the Trump administration announced agreements with pharmaceutical companies aimed at lowering costs for people paying out of pocket or covered under Medicare or Medicaid.
Credits: iStock
Every year on December 3, the International Day of Persons with Disabilities (IDPD) is observed. It is a UN day that works towards promoting the rights and well-being of persons with disabilities at every level of society and development, and to raise awareness of the situation of personal with disabilities in all aspects of life.
At the headquarters of the World Health Organization (WHO), IDPD events are organized to educate the public, raise awareness, advocate for political will and resources, and celebrate WHO's achievement.
As per the United Nations Convention on the Rights of Persons with Disabilities or the UNCRPD, persons with disabilities are individuals with long-term physical, mental, intellectual, or sensory impairments that restrict their ability to participate in society on equal terms.
India’s commitment to accessibility stems from Article 9 of the UNCRPD, which mandates equal access to physical spaces, transportation, and services.
Rights of Persons with Disabilities Act, 2016: India’s RPwD Act, 2016, aligns with this definition and adds the term “benchmark disability,” which refers to individuals with at least 40% of a specified disability.
This Act sets accessibility standards for public spaces and digital platforms.
The Act increased reservation for PwDs from 3% to 4% in jobs and 3% to 5% in higher education.
The RPwD Act expanded the list of disabilities from 7 to 21 categories, including conditions like:
As per the 2011 Census, India is home to 26.8 million persons with disabilities, which means at least 2.21% of its total population. The highest prevalence is observed between the age group of 10 to 19 years. Among them, 20% have mobility impairments, 19% have visual impairment, 19% have hearing impairment, and 8% suffer from multiple disabilities.
This year, the theme is 'Fostering disability-inclusive societies for advancing social progress, while in 2024, the theme was: 'Amplifying the leadership of persons with disabilities for an inclusive and sustainable future'.
This was first established by the United Nations in 1992, to raise awareness and creating inclusive society for all. The aim was to create an inclusive, accessible, and equitable society where no one is left behind.
The main role of this day in observance is to educate people. As more than 1 billion people in the world, which is around 20% of the world population live with some kind of disability. Thus, in such a scenario it is important for people to be sensitive towards their need. This day also helps address and solve the barriers faced by people living with disabilities, which include:
Limited access to education and employment
Inaccessible public spaces and transportation
Social stigma and discrimination
Insufficient healthcare and rehabilitation services
Lack of assistive technologies and accessible digital platforms
Credits: Instagram
La Toya Jackson’s latest Instagram post has left fans more worried than ever. The 69 year old singer shared a series of photos earlier this week wearing a fitted red top, black pants and gold pointy heels. She added a chunky chain belt and a bracelet, posing in different angles for her followers. But what stood out most was how noticeably thin she looked, especially in the side profile shot.
Her caption was cheerful, wishing everyone a great week and sending love. The comment section quickly filled up, but instead of the usual compliments, many people expressed concern. Some fans urged others to be kind and pointed out that La Toya has always been naturally petite. Others felt something deeper might be going on. One comment read that it seemed like she may be dealing with “some health challenges”.
The post comes just weeks after La Toya shared a short, somewhat cryptic video from what looked like a doctor’s office. She did not explain why she was there but told her followers she hoped all her results would be good.
In another clip she hinted that doctor visits had become frequent, joking that she was “constantly getting check ups”. Despite the glimpses into her medical visits, she has not revealed what health issues she may be facing, leaving fans to worry and speculate.
While her situation remains private, her photos have opened up a larger conversation about what happens when someone becomes extremely thin. Many people assume being skinny is automatically healthy, but that is not always true. There is a point where being underweight can put real strain on the body.
Being underweight means your body does not have the amount of nutrition and energy stores it needs to function well. One common guideline used by experts is body mass index. For most adults, a BMI below 18.5 is considered underweight. In children and teenagers, being below the 5th percentile for BMI indicates underweight.
Sometimes extreme thinness is easy to spot, but people who have always been slim may not notice when their weight drops into an unhealthy range. Children who are underweight may simply seem smaller or leaner than others their age, which can make early signs easy to miss.
When the body does not get enough nutrients or calories, it begins to show that stress in different ways. Some of the early signs include constant tiredness, weakness, dizziness or feeling lightheaded.
The heart can also slow down, leading to a low pulse and low blood pressure. Hair may become thinner or start falling out and the immune system becomes weaker, which means a person might catch infections more easily and take longer to recover.
Emotional and hormonal changes are also common. Irritability, low mood or a sense of apathy can appear. In women, periods may become irregular or stop completely. Severe underweight can affect fertility and make it harder to get pregnant.
These symptoms do not happen overnight. They develop gradually as the body runs lower on essential nutrients. This is why sudden or unexplained weight loss should always be taken seriously.
© 2024 Bennett, Coleman & Company Limited